ProfileGDS4718 / 1558164_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 30% 28% 36% 38% 47% 67% 48% 37% 32% 30% 39% 37% 43% 55% 52% 48% 44% 60% 57% 35% 41% 44% 45% 45% 45% 43% 34% 66% 38% 46% 40% 57% 35% 36% 50% 59% 55% 37% 37% 48% 38% 60% 42% 61% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.5387930
GSM549102patient 115, normal, homogenized [OPG study]4.4817128
GSM549104patient 119, normal, homogenized [OPG study]4.8173636
GSM549108patient 138, normal, homogenized [OPG study]4.9354338
GSM549119patient 077, normal, homogenized [OPG study]5.3352747
GSM549133patient 032, cancer, homogenized [OPG study]6.615567
GSM549139patient 042, cancer, homogenized [OPG study]5.4053448
GSM549099patient 107, normal, homogenized [OPG study]4.8775137
GSM549109patient 139, normal, homogenized [OPG study]4.644732
GSM549110patient 046, normal, homogenized [OPG study]4.528130
GSM549114patient 063, normal, homogenized [OPG study]4.8982939
GSM549122patient 082, normal, homogenized [OPG study]4.8382137
GSM549134patient 033, cancer, homogenized [OPG study]5.1251943
GSM549136patient 036, cancer, homogenized [OPG study]5.7637155
GSM549140patient 044, cancer, homogenized [OPG study]5.5932652
GSM549111patient 047, normal, homogenized [OPG study]5.3674748
GSM549113patient 057, normal, homogenized [OPG study]5.1225344
GSM549132patient 031, cancer, homogenized [OPG study]6.0940960
GSM549137patient 038, cancer, homogenized [OPG study]5.9502157
GSM549142patient 047, cancer, homogenized [OPG study]4.9022235
GSM549100patient 110, normal, homogenized [OPG study]5.0858741
GSM549107patient 135, normal, homogenized [OPG study]5.1370544
GSM549115patient 068, normal, homogenized [OPG study]5.1525745
GSM549116patient 072, normal, homogenized [OPG study]5.2270145
GSM549120patient 078, normal, homogenized [OPG study]5.214845
GSM549131patient 030, cancer, homogenized [OPG study]5.0858743
GSM549118patient 074, normal, homogenized [OPG study]4.7081434
GSM549129patient 027, cancer, homogenized [OPG study]6.629366
GSM549123patient 088, normal, homogenized [OPG study]4.8842738
GSM549124patient 006, cancer, homogenized [OPG study]5.3325746
GSM549126patient 015, cancer, homogenized [OPG study]5.0048540
GSM549128patient 025, cancer, homogenized [OPG study]5.9292257
GSM549103patient 117, normal, homogenized [OPG study]4.826635
GSM549117patient 073, normal, homogenized [OPG study]4.7747736
GSM549138patient 041, cancer, homogenized [OPG study]5.493650
GSM549141patient 045, cancer, homogenized [OPG study]6.0572759
GSM549130patient 028, cancer, homogenized [OPG study]5.7951355
GSM549101patient 111, normal, homogenized [OPG study]4.8831337
GSM549105patient 128, normal, homogenized [OPG study]4.8930137
GSM549106patient 134, normal, homogenized [OPG study]5.3416848
GSM549112patient 048, normal, homogenized [OPG study]4.878938
GSM549125patient 011, cancer, homogenized [OPG study]6.1087860
GSM549127patient 024, cancer, homogenized [OPG study]5.1074242
GSM549135patient 035, cancer, homogenized [OPG study]6.1532361